Study on the role and mechanism of lncRNA in the remodeling of atrial energy metabolism in rabbits with atrial fibrillation based on nano sensor technology

References

• Du X, Dong J, Ma C, et al. Is atrial fibrillation a preventable disease. J Am Coll Cardiol. 2017;69(15):1968–1982.
   PubMed Web of Science ®Google Scholar
• Sun L, Yan S, Wang X, et al. Metoprolol prevents chronic obstructive sleep apnea-induced atrial fibrillation by inhibiting structural, sympathetic nervous and metabolic remodeling of the atria. Sci Rep. 2017;7(1):1–13.
   PubMed Web of Science ®Google Scholar
• Wiersma M, van Marion D, Wüst RCI, et al. Mitochondrial dysfunction underlies cardiomyocyte remodeling in experimental and clinical atrial fibrillation. Cells. 2019;8(10):1202.
   PubMed Web of Science ®Google Scholar
• Opacic D, van Bragt KA, Nasrallah HM, et al. Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation. Cardiovasc Res. 2016;109(4):527–541.
   PubMed Web of Science ®Google Scholar
• Li X, Yang X, Li Y, et al. Mitochondria and the pathophysiological mechanism of atrial fibrillation. Curr Pharm Des. 2018;24(26):3055–3061.
   PubMed Web of Science ®Google Scholar
• Jie QQ, Li G, Duan JB, et al. Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation. Biochem Biophys Res Commun. 2019;517(1):8–14.
   PubMed Web of Science ®Google Scholar
• Sallam T, Sandhu J, Tontonoz P, et al. Long noncoding RNA discovery in cardiovascular disease: decoding form to function. Circ Res. 2018;122(1):155–166.
   PubMed Web of Science ®Google Scholar
• Lu J, Xu FQ, Guo JJ, et al. Long noncoding RNA GAS5 attenuates cardiac fibroblast proliferation in atrial fibrillation via repressing ALK5. Eur Rev Med Pharmacol Sci. 2019;23(17):7605–7610.
   PubMed Web of Science ®Google Scholar
• Lou Q, Liu GZ, Lv JC, et al. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation. Eur J Pharmacol. 2020;881(1):173120.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou X, Li Z, et al. Prevention of atrial fibrillation by using sarcoplasmic reticulum calcium atpase pump overexpression in a rabbit model of rapid atrial pacing. Med Sci Monit. 2017;23(1):3952.
   PubMed Web of Science ®Google Scholar
• Zhao JB, Zhu N, Lei YH, et al. Modulative effects of lncRNA TCONS_00202959 on autonomic neural function and myocardial functions in atrial fibrillation rat model. Eur Rev Med Pharmacol Sci. 2018;22(24):8891–8897.
   PubMed Web of Science ®Google Scholar
• Wu J, Han D, Shi R, et al. Identification of atrial fibrillation‐associated lncRNAs in atria from patients with rheumatic mitral valve disease. Microsc Res Tech. 2019;82(7):1136–1144.
   PubMed Web of Science ®Google Scholar
• Du J, Li Z, Wang X, et al. Long noncoding RNA TCONS‐00106987 promotes atrial electrical remodelling during atrial fibrillation by sponging miR‐26 to regulate KCNJ2. J Cell Mol Med. 2020;24(21):12777–12788.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang X, Wang W, et al. Altered long non-coding RNA expression profile in rabbit atria with atrial fibrillation: TCONS_00075467 modulates atrial electrical remodeling by sponging miR-328 to regulate CACNA1C. J Mol Cell Cardiol. 2017;108(1):73–85.
   PubMed Web of Science ®Google Scholar
• Bai F, Liu Y, Tu T, et al. Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway. Lipids Health Dis. 2019;18(1):1–9.
   PubMed Web of Science ®Google Scholar
• Liu GZ, Hou TT, Yuan Y, et al. Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR‐α/sirtuin 1/PGC‐1α pathway. Br J Pharmacol. 2016;173(6):1095–1109.
   PubMed Web of Science ®Google Scholar
• Chen G, Guo H, Song Y, et al. Long non‑coding RNA AK055347 is upregulated in patients with atrial fibrillation and regulates mitochondrial energy production in myocardiocytes. Mol Med Rep. 2016;14(6):5311–5317.
   PubMed Web of Science ®Google Scholar
• Chu Y, Yang Q, Ren L, et al. Late sodium current in atrial cardiomyocytes contributes to the induced and spontaneous atrial fibrillation in rabbit hearts. J Cardiovasc Pharmacol. 2020;76(4):437–444.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang S, Liu Z, et al. Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 2018;391(11):1179–1190.
   Google Scholar
• Ferguson MA, Sutton RM, Karlsson M, et al. Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. J Bioenerg Biomembr. 2016;48(3):269–279.
   PubMed Web of Science ®Google Scholar
• Dey S, Demazumder D, Sidor A, et al. Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure. Circ Res. 2018;123(3):356–371.
   PubMed Web of Science ®Google Scholar
• Yurista SR, Silljé HHW, Rienstra M, et al. Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes. Cardiovasc Diabetol. 2020;19(1):1–7.
   PubMed Web of Science ®Google Scholar
• Soccio RE, Li Z, Chen ER, et al. Targeting PPARγ in the epigenome rescues genetic metabolic defects in mice. J Clin Investig. 2017;127(4):1451–1462.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Henriksen K, Genovese F, et al. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes. Diabetologia. 2017;60(1):50–59.
   PubMed Web of Science ®Google Scholar
• Dong J, Zhao J, Zhang M, et al. β3-adrenoceptor impairs mitochondrial biogenesis and energy metabolism during rapid atrial pacing-induced atrial fibrillation. J Cardiovasc Pharmacol Ther. 2016;21(1):114–126.
   PubMed Web of Science ®Google Scholar